Skip to main content
Premium Trial:

Request an Annual Quote

Galileo Genomics Gets $CA7 Million Loan from Investissement Quebec

NEW YORK, Jan. 19 (GenomeWeb News) - Galileo Genomics has received a loan of $CA7 million ($5.39 million) from Investissement Quebec, the company said today.


Galileo, based in Montreal, plans to use the additional funding for its research. Applying its chromozoom technology, the company is trying to find groups of genes associated with more than 20 common diseases by examining DNA samples from the Quebec Founder Population.


Earlier this month, Galileo raised $CA11.15 million ($8.58 million) in equity financing.


The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.